Search

Insulet Corp

Avatud

SektorTervishoid

167.09 1.33

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

164.31

Max

172.83

Põhinäitajad

By Trading Economics

Sissetulek

-11M

91M

Müük

-22M

762M

P/E

Sektori keskmine

38.3

62.58

Aktsiakasum

1.42

Kasumimarginaal

11.96

Töötajad

5,400

EBITDA

-23M

154M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+34.17% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-278M

12B

Eelmine avamishind

165.76

Eelmine sulgemishind

167.09

Uudiste sentiment

By Acuity

63%

37%

295 / 340 Pingereas Healthcare

Insulet Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. juuli 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24. juuli 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22. juuli 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20. juuli 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Võrdlus sarnastega

Hinnamuutus

Insulet Corp Prognoos

Hinnasiht

By TipRanks

34.17% tõus

12 kuu keskmine prognoos

Keskmine 221.38 USD  34.17%

Kõrge 294 USD

Madal 172 USD

Põhineb 22 Wall Streeti analüütiku instrumendi Insulet Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

22 ratings

18

Osta

3

Hoia

1

Müü

Sentiment

By Acuity

295 / 340 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat